The ICGN mouse is a model for nephrotic syndrome (NS) which presents with proteinuria, hyperlipidemia, and edema. In this study we attempted to identify the gene(s) responsible for NS. By analyzing albuminuria in 160 (ICGN · MSM)F 1 · ICGN backcross progenies, we found that NS in the ICGN mouse is caused by more than one gene. We then performed a quantitative trait locus (QTL) analysis and detected a QTL with a very high LOD score peak in the telomeric region of Chr 15. By analyzing the nucleotide sequence of 22 genes located close to the QTL, we found that the tensin2 gene of the ICGN mouse possessed an 8-nucleotide deletion mutation in exon 18, leading to a frameshift and giving rise to a terminal codon at a premature position. Analyses of in situ hybridization and immunohistochemistry revealed that tensin2 was expressed in podocytes and tubular epithelial cells in normal mice but not in the ICGN mouse. These data raise the possibility that a mutation of the tensin2 gene is responsible for NS of the ICGN mouse and tensin2 is a prerequisite for the normal kidney function.
Introduction
Nephrotic syndrome (NS) is among the most common kidney diseases in children and also occurs frequently in adults. In this disease the filtration barrier of the kidney is altered allowing massive amounts of protein from serum to be lost, leading to low oncotic pressure in serum and leakage of fluid from the bloodstream into the surrounding tissues causing edema. These clinical symptoms correlate with dramatic structural alterations in glomerular epithelial cells (podocytes), including retraction and effacement (spreading) of the distal foot processes of podocytes overlying the glomerular basement membrane (GBM), disruption and redistribution of the dense concentrations of actin within these processes, and in some areas detachment of podocytes from the GBM (Caulfield et al. 1976 ; Ryan and Karnovsky 1975; Smoyer et al. 1998 ; Somlo and Mundel 2000) .
ICGN is a strain of mouse with hereditary NS. This strain was derived from an outbred ICR colony at the National Institute of Health (Japan) in 1986 (Ogura et al. 1989 ). Affected ICGN mice show podocyte damage, albuminuria, and edema. The NS of the ICGN mouse was reported to be controlled by a single recessive locus, nep, when a preliminary genetic analysis was performed using albuminuria as a symptom of the NS (Kurosawa et al. 1993 ). Furthermore, the nep locus was mapped to Chr 15 by preliminary genetic analysis in which the nep locus was treated as a single recessive locus by omitting ambiguous data that showed mild albuminuria (Okamoto et al. 2001 ). Histologic examinations demonstrated that glomerular lesions consisted of a marked thickening of the GBM, multilaminar splitting of the lamina densa of the GBM, and fusion of the epithelial foot processes (Ogura et al. 1991 ). Cellular and extracellular matrix abnormalities have been also described in the ICGN mouse kidney, including (a) excessive accumulation of extracellular matrix components such as type I, III, and IV collagens, laminin, fibronectin, and tenastin (Uchio et al. 1999 ), (b) decreased matrix metalloproteinase activity (Uchio et al. 2000) , and (c) abnormal expression of integrin a1, a2, a5 and b1 subunits in glomeruli (Uchio-Yamada et al. 2001 ). Thus, the ICGN mouse is thought to be a good animal model for NS as well as for chronic renal disease (Mizuno et al. 1998 ). Therefore, we attempted to find the gene(s) responsible for NS.
An efficient method for identifying the gene(s) responsible for inheritable diseases in animal models is chromosomal mapping of their loci. Thus, we performed a quantitative trait locus (QTL) analysis and succeeded in mapping a main QTL responsible for NS to Chr 15. We finally found that the tensin2 gene is mutated with a frameshift by sequencing several genes located in this region. The tensin2 gene was reported as Tenc1, tensin-like C1 domaincontaining phosphatase, in Mouse Genome Informatics (http://www.informatics.jax.org/). We propose the gene symbol Tns2 for Tensin2/Tenc1 in this article as unifying gene symbols for the tensin family. In this article we show that a mutation of the Tns2 gene is the presumptive cause of NS in the ICGN mouse and discuss the role of Tns2 in kidney function.
Materials and methods
Animals. Animal breeding rooms were maintained at 23 ± 2°C and 50% ± 10% relative humidity with a 12-hour light-dark cycle (lights on from 8:00 a.m. to 8:00 p.m.). Research was conducted according to the Guidelines for the Care and Use of Laboratory Animals of both the Nagoya City University Medical School and the Graduate School of Veterinary Medicine, Hokkaido University. The experimental protocol was approved by the Institutional Animal Care and Use Committee of both the Nagoya City University Medical School and the Graduate School of Veterinary Medicine, Hokkaido University.
Estimation of the level of albuminuria. Urine was collected and analyzed using SDS-PAGE. Gels were stained with Coomassie Brilliant Blue R-250 and analyzed with NIH image software. The intensity of the albumin band in urine samples at 66.1 kDa was estimated as an arbitrary unit for the albuminuria with bovine serum albumin (BSA) as the standard.
QTL analysis. Male ICGN mice were mated with female MSM mice, and the F 1 females were backcrossed to ICGN males. A total of 160 backcross progenies were generated and genotyped with respect to 127 microsatellite markers showing polymorphisms between the ICGN and the MSM mice. QTL analysis was performed with arbitrary units for the albuminuria as quantitative traits using the QTL software Map Manager QTb2168k.
Reverse transcription (RT)-PCR and sequence analysis of the Tns2 gene. Total RNA was extracted from the kidneys of 6-week-old male C57BL/6J, ICR, and ICGN mice using TRIZOL reagent (Invitrogen), and complementary (c)DNA templates were generated by RT using ReverTra Ace (TOYOBO). Oligonucleotide primers covering the entire coding region of the Tns2 gene were designed based on the reported mouse Tns2 cDNA sequence (GenBank accession No. NM-153533). Polymerase chain reaction (PCR) was performed using the following primers: T-1F: 5¢-AGAGGAAGGAGAGACAGGC-3¢; T-1R: 5¢-TGCT GTAGTGCATATAAGC-3¢; T-2F: 5¢-AAAGCCATG GAGACGTGGC-3¢; T-2R: 5¢-AGCAGGCTCTGTC GTGTTG-3¢; T-3F: 5¢-TTTCCAAGCCTCAGTGG AG-3¢; T-3R: 5¢-GCTGGACGGTAGCCAAAGT-3¢; T-4F: 5¢-TGGAGAAGAGACGCCTCTG-3¢; T-4R: 5¢-CAGACAGCTCTGAAGAAGC-3¢; T-5F: 5¢-TGG AGGGATGGCTCCAGTGG-3¢; T-5R: 5¢-CTGGAC AAACTTGACATTGC-3¢; T-6F: 5¢-CGTCGCCAC-CAGCCAGAAG-3¢; T-6R: 5¢-CTTTCACAGGGGC CAGGCC-3¢. PCR products were purified and directly sequenced with a set of suitable primer pairs or else cloned with pGEM-T Easy Vector Systems (Promega) and then sequenced. Sequencing was performed with an ABI BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems) according to the manufacturer's instructions.
Northern blot analysis. Electrophoresis, transfer, and hybridization were performed using standard methods. Total RNAs prepared from kidneys of ICR and ICGN mice were hybridized with a 32 P-labeled cDNA probe of the Tns2 gene (nt567-nt1280) to examine messenger (m)RNA expression in the kidney.
In situ hybridization. For synthesizing the Tns2-antisense riboprobe, a 122-bp PCR product (nt47-nt168) was subcloned with pGEM-T Easy Vector Systems (Promega), digested with PstI, and transcribed in the presence of Digoxigenin (DIG) RNA Labeling Mix (Roche) with T7 or sp6 RNA polymerase.
In situ hybridization using the DIG-labeled probes was performed as described previously (Butler et al. 2001 ). Briefly, 5-lm-thick paraffin-embedded tissue sections were deparaffinized in xylene, rehydrated in an ethanol series, and washed for 5 min in phosphate-buffered saline (PBS). Slides were incubated overnight with the antisense or sense probe at 53°C in a humidified chamber. Signals were detected with alkaline phosphatase-conjugated anti-DIG antibody with freshly prepared substrate (nitroblue tetrazolium salt and 5-bromo-4-chloro-3-indolylphosphate) (Boehringer Mannheim). The reaction was stopped by soaking the slides in 10 mM TrisHCl (pH 8.0) and 1 mM ethylenediaminetetraacetic acid (EDTA).
Anti-Tns2 antibody. A rabbit polyclonal antibody against Tns2 was produced by using a synthetic peptide, MKPRKAEPHSFREK+C, corresponding to the N-terminal region specific to Tns2, whose sequence was not present in other tensins. AntiTns2-specific antibody was purified by affinity chromatography using the standard protocol.
Western blot analysis. Kidney tissues were homogenized with lysis buffer consisting of 150 mM NaCl, 50 mM Tris-HCl (pH 8.0), 1 mM phenylmethanesulfonyl fluoride (PMSF), and 1 lg/ml leupeptin. The protein concentration was determined with a Bradford assay reagent (Sigma). Proteins were separated by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). The Tns2 protein was detected with a specific antibody using the standard methods.
Immunohistochemistry. Kidney tissues were fixed with formalin and embedded in paraffin. Sections 3 lm thick were processed according to a routine histologic procedure. After rehydration, antigen was retrieved by autoclaving the sections for 5 min in 2· standard saline citrate (SSC). Sections were then incubated with 3% H 2 O 2 in water for 10 min to inhibit endogenous peroxidase activity and heated by using a pressure cooker in 0.01 M citrate buffer (pH 6.0) at 120°C for 5 min. For immunohistochemistry with double staining, sections were first incubated with anti-Wilms' tumor antigen-1 (WT-1), a marker for the podocytes (Santa Cruz), Envision-horseradish peroxidase rabbit (Dako), and treated with diaminobenzidine (Dako). Then the sections were incubated with anti-Tns2, Envision-alkaline phosphatase (Dako), and New Fuchsin (Dako). After washing with water, the sections were counterstained with hematoxylin and mounted with Entellan (Merck).
Results
Detection of albuminuria. We produced 160 progenies of (ICGN x MSM)F 1 · ICGN backcrosses. The urine samples collected were analyzed with SDS-PAGE to estimate the albumin contents. It was found that the protein fraction with 66.1 kDa was an albumin fraction. The albumin band was identified in ICGN mice but not in MSM and F 1 mice (Fig. 1A) . Backcross progenies showed various degrees of albuminuria and did not segregate into the ICGN and MSM types (Fig. 1B, C) , suggesting that albuminuria was caused by multiple genetic loci.
QTL analysis. Since albuminuria in ICGN mice appeared to be controlled by multiple genetic loci, mapping was performed by QTL analysis. The analysis was performed with 127 microsatellite markers that span the mouse genome at average intervals of 10À20 cM. A significant QTL was identified in the telomeric region of Chr 15 and the LOD score peak was located near the D15Mit42 locus (55.5 cM). No other significant QTLs were detected. Based on the mouse genome database, Aqp2, Aqp6, and Itga5 were attractive candidate genes because they are located near the D15Mit42 locus and are expressed in the kidney with particular functions. Although nucleotide substitutions were found in all three genes between the ICGN and the MSM mice or a normal strain such as ICR or C57BL/6J mice, they were all silent mutations. We then used these nucleotide polymorphisms and remade the genetic map. We subsequently detected two backcross progenies that showed recombination between the Itga5 and D15Mit42 loci. The renewal LOD score of the peak in our final version of the genetic map was 26.1 at the Itga5 locus of the telomeric region of Chr 15 (Fig. 2) . We investigated the mouse genome database again and selected 22 genes located between the D15Mit42 and Itga5 loci to narrow the region where a gene responsible for NS would be located (Fig. 3A) . To detect the single nucleotide polymorphism, sequencing the coding regions of these genes was performed. We subsequently found that the Tns2 gene showed a mutation in the ICGN mouse. The Tns2 cDNA extracted from the ICGN mouse kidney revealed a deletion of 8 nucleotides (nt1477-nt1484) in exon 18 of the ICGN Tns2 gene (Fig. 3C) . It is expected that this mutation causes a frameshift, leading to a terminal codon at a premature position, nt1538 (Fig. 3D) . We examined the nucleotide sequence of the Tns2 gene obtained from other mouse strains such as ICR, C57BL/6J, BALB/c, C3H/HeN, AKR/N, DBA/2J, CBA/J, and MSM/Ms. However, no strain was found with the same mutation in the Tns2 gene, suggesting that the 8-nucleotide deletion is not a polymorphism.
Detection of the Tns2 mRNA and protein. The expression of Tns2 mRNA in various tissues of normal mice was examined by RT-PCR. Tns2 mRNA was ubiquitously expressed in all organs examined. The intensity of the bands for RT-PCR in the ICGN mouse was low in all organs compared with that of the ICR mouse kidney (Fig. 4A) . We further analyzed the expression of the Tns2 gene in the ICGN mouse kidney. The 4.1-kb transcript was detected in kidney from 7-month-old ICR and ICGN mice, but the band's intensity was extremely low in the ICGN mouse, confirming much less of the Tns2 transcript in the ICGN mouse kidney (Fig. 4B) . The decrease or loss of the Tns2 transcript in the ICGN mouse seems to be a result of nonsense-mediated mRNA decay (Mendell and Dietz 2001) . Next, the Tns2 protein in the kidney was detected by Western blotting. Blotting with anti-Tns2 antibody revealed a positive signal on the 173-kDa band in the kidney of ICR but not of ICGN mice (Fig. 4C) . Furthermore, the band for a premature Tns2 protein with an expected size of 60 kDa was not detected in the ICGN mouse kidney (data not shown).
Identification of the cells expressing Tns2. To consider the role of Tns2, localization of Tns2 in the kidney was examined in normal mice. We performed in situ hybridization of the Tns2 mRNA in the kidney of ICR mice using a DIG-labeled probe. In situ hybridization yielded a strong signal in podocyte-like cells of the glomeruli and epithelial cells of the tubules (Fig. 5A) . Tns2 mRNA was undetectable in the ICGN mouse kidney section (data not shown). To confirm that the Tns2-expressing cells in the glomeruli are podocytes, a marker for the podocytes, WT-1 (Sanden et al. 2003 ) was stained with a specific antibody in the same slide. The nuclei of the cells positive for Tns2 in the glomeruli were also stained with anti-WT-1 antibody (Fig. 5B) , confirming that they were podocytes. The immunohistochemical double staining also revealed that positive signals for Tns2 were detected in podocytes, parietal epithelial cells in the glomeruli, and the tubular epithelial cells of the ICR mouse kidney but not of the ICGN (Fig. 5C) . Thus, we concluded that Tns2 is expressed in podocytes and tubular epithelial cells in the normal kidney but not in the ICGN mouse kidney.
Discussion
The kidney glomerulus is a highly specialized structure that ensures selective ultrafiltration of plasma so that essential proteins are retained in the blood. The common denominator in a variety of human and experimental glomerular diseases, including diabetes mellitus, focal segmental glomerulosclerosis, and systemic lupus erythematosus, is glomerular dysfunction involving a massive loss of protein in the urine (proteinuria) (Kerjaschki 2001; Somlo and Mundel 2000) . These diseases are characterized by numerous morphologic changes in podocytes, including retraction (effacement) of podocyte foot processes and, frequently, detachment of podocytes from the underlying GBM. The foot process effacement is a process that correlates closely with the development of proteinuria in both human disease and experimental models. The detachment of effaced foot processes from the GBM is generally considered the most severe structural manifestation of NS (Caulfield et al. 1976; Reiser et al. 2002; Ryan and Karnovsky 1975; Smoyer et al. 1998; Somlo and Mundel 2000) . Kim et al. (2001) showed that repeated injections of puromycin aminonucleoside also augmented podocyte loss and that the regions devoid of podocytes developed glomerulosclerosis. In this report, the glomerulosclerosis was initiated only when podocyte numbers decreased by 10%À20%. Therefore, recent studies have focused on the causes underlying podocytopenia. The etiology of podocytopenia includes apoptosis, detachment, and the inability or a lack of podocytes to proliferate (Mundel and Shankland 2002) . The discovery and mutational analysis of several podocyte proteins, including NEPHRIN (Kestila et al. 1998 All glomeruli of ICGN mice were affected by 14 days after birth. Electron microscopy showed the fusion and loss of epithelial cell foot processes in severely affected glomeruli (Ogura et al. 1994 (Ogura et al. , 1995 . In this article we have identified Tns2 as a candidate gene responsible for NS in the ICGN mouse, in which 8 nucleotides are deleted from exon 18, resulting in a frameshift. The results of both Northern and Western blot analyses showed a loss of expression of Tns2 in the kidney of the ICGN mouse.
Tensin is an actin-binding protein that is concentrated in some submembranous cytoskeletal focal contacts (Weigt et al. 1992 ). In addition to its three actin-binding domains, tensin protein contains a Src homology (SH) 2 domain that mediates proteinprotein contacts and is shared by a variety of signal transduction molecules. It has recently been reported that three molecules, Tns2, Tns3, and Tns4, show extensive homology to Tns1, with the most conserved areas in the N-and C-terminal regions (Lo 2004 ). Lo et al. (1997) generated Tns1-null mice to explore the role of Tns1. These mice appeared nor- mal and healthy for several months but eventually developed cystic kidneys. Progressive cyst formation led to kidney degeneration and death from renal failure. On the other hand, the ICGN mouse shows a very different pathologic phenotype in the kidney compared with the Tns1-null mouse. Thus, we attempted to examine the localization of Tns2 in the kidney tissue by in situ hybridization and immunohistochemistry. Both histologic examinations revealed that Tns2 is present in glomerular podocytes and tubular epithelial cells (Fig. 5) . In contrast, Tns1 is concentrated in glomerular mesangium cells and basal aspects of the tubular cells (Lo et al. 1997; Takahara et al. 2004) . The difference in the distribution of the Tns1 and Tns2 proteins, namely, the difference in the glomeruli, may account for the different phenotypes in null mice for each tensin family protein.
We cannot yet fully explain how the Tns2 mutation leads to morphologic changes of the glomerulus and proteinuria in the ICGN mouse, but we can speculate based on the conserved Tns2 domain and subcellular localization. First, mobility is dependent on cell adhesion. Tns2 is localized to the sites of focal adhesions and expression of Tns2 is able to promote cell migration on fibronectin in a cell migration assay (Chen et al. 2002) . Also, Chen et al. (2003) showed that the SH2 domain of the Cterminal region is critical for Tns1-mediated cell migration. The SH2 domain of Tns2 is supposed to play the same role. Therefore, without Tns2 cell adhesion might be weakened in the kidney, leading to an alteration in the adhesive properties of cells and subsequently to the disruption of cell-cell and cell-GBM interactions, detachment of podocytes, proteinuria, and glomerulosclerosis. Second, podocyte foot processes are known to contain high concentrations of actin. F-actin localizes to the submembranous regions of all three membrane domains of podocytes (Drenckhahn and Franke 1988) . The membrane at the foot processes' soles is attached to this actin meshwork via dystroglycan and utrophin or via integrin, talin, paxillin, and vinculin. This actin fiber formation is a highly dynamic process that is governed by continuous assembly and disruption of filaments. The submembranous actin cytoskeleton is important for maintaining the infrastructure of the membrane domains and for the stability of the podocyte's shape (Kerjaschki 2001) . This critical role is highlighted by the finding that suppression of the actin-bundling protein ACTN-4 (Michaud et al. 2003) or actinbinding protein CD2-AP (Shih et al. 1999 ) by genetic engineering in mice causes podocyte damage. Tns2 is an actin-binding protein and speculated to be a mediator that facilitates the recruitment of actin filaments (Chen et al. 2002) . Immunofluorescence microscopy with fluorescence-tagged Tns2 revealed a subcellular localization at the end of actin stress fibers and colocalization with vinculin at focal adhesions (Chen et al. 2002) . Therefore, the absence of Tns2 has a direct or indirect effect on the actin cytoskeleton of podocytes. These hypotheses require further experimental investigation. However, the results presented here suggest that morphologic changes to podocytes and proteinuria result from a loss of function of the adhesion molecule Tns2.
In this study, NS of the ICGN mouse was attributed to a mutation of the Tns2 gene. This may be inconsistent with the result that it is controlled by multiple genes, since the individual level of the albuminuria in backcross progenies could not be segregated into two groups (Fig. 1C) . However, in QTL analysis we detected only one significant QTL located in the telomeric region of Chr 15 with a very high LOD score. This suggests that NS of the ICGN mouse is caused mostly by a mutation of the Tns2 gene with minimal modifications by unknown genetic factors not detected in the QTL analysis at this time. This is consistent with the interpretation derived from a preliminary genetic analysis that NS of the ICGN mouse is controlled by a single recessive locus (Kurosawa et al. 1993; Okamoto et al. 2001 ).
In addition, the results of RT-PCR showed that the Tns2 mRNA is ubiquitously present in various tissues (Fig. 4A) . However, these organs in the ICGN mouse do not show detectable anomalies, even in the terminal stage (Ogura et al. 1989 ). There may be other molecules in these tissues that can compensate for the absence of Tns2. Tns2 has a domain that shows high homology to the N-and C-terminal regions of Tns1. However, the C1 (protein kinase C conserved region 1) domain is unique to Tns2, and central regions are highly divergent in the ttensin family (Lo 2004 ). The central region of Tns2 is very rich in proline residues, which provide potential binding sites for interacting modules such as SH3 and WW domains (Chen et al. 2002) . Thus, the C1 domain and central region may contribute to the regulation of the signal pathway that determines unique biological roles not substituted by Tns1 and other molecules in the kidney. Therefore, it is important to determine in the future which signal pathways Tns2 participates in for the maintenance or disruption of the interaction between podocytes and GBM.
In conclusion, this study has shown that the Tns2 gene in the ICGN mouse, an animal model for NS, possesses an 8-bp nucleotide deletion, leading to a frameshift that produces a terminal codon at a premature position. This result raises the possibility that a deficiency of Tns2 in the kidney is responsible for NS in the ICGN mouse, although full confirmation has to wait for further investigations such as transgenic rescue or production of Tns2-knockout mice. Tns2 deficiency may be of the reason why some patients have familial or sporadic NS.
